Global Metabolomics Market Revenue, Demand, Opportunity, Segment and Key Trends

The metabolomics technology market majorly comprises detection techniques such as mass spectrometry (MS) and nuclear magnetic resonance spectroscopy (NMR), and separation techniques such as gas chromatography.

The new range of enhanced technologies for accuracy and precision in metabolomics research and growth in emerging markets due to increasing investments presents significant growth opportunities for players in the Metabolomics Market.

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=900

The research report discusses key market drivers, restraints, opportunities, and challenges in the global metabolomics technology market and its submarkets.

key players operating in the Global Metabolomics Market;

The global metabolomics technology market is highly competitive and fragmented in nature. Prominent players in the global market are Thermo Fisher Scientific (U.S.), Agilent Technologies (U.S.), Danaher Corporation (U.S.), Waters Corporation (U.S.), and Shimadzu Corporation (Japan). Other leading players in this market include Bio-Rad Laboratories (U.S.), Bruker Corporation (U.S.)

Thermo Fisher Scientific, Inc. (U.S.) held the leading position in the global market. Its prominence in this market can be attributed to its diversified product portfolio that includes a wide range of products for metabolomics instrumentation tools and services. The company strongly invests in R&D activities to improve its existing product portfolio, as it has a strong pipeline of products for the growing market.

Major Drivers Impacting the Metabolomics Market;

• Availability of government and private funding
• Increasing pharmaceutical and biotech R&D expenditure
• Technological advancements
• Growing demand for personalized medicine
• Increasing the use of metabolomics in toxicology testing

Key Questions Addressed in this research study:

• Most of the metabolomics market players have new product launch and product enhancements as the key growth strategies. Where will it take the industry in the mid to long term?
• How are the potential areas for investment using strategic evaluation in metabolomics technology market?

Global Metabolomics Market Segmentation:

Based on product & service, the market is segmented into metabolomics instruments and metabolomics bioinformatics tools & services. Metabolomics bioinformatics tools & services are expected to grow at the highest CAGR during the forecast period. The ability of metabolome analysis software tools for interpreting the results of analytical experiments and understand the potential of metabolomics data generated from analytical tools are expected to drive the growth of this segment.

Request Research Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=900

Metabolomics Market by Geography

• North America
• Europe
• Asia Pacific (APAC)
• Latin America
• Middle East & Africa

Metabolomics Market | Business Overview, Products and Services, Key Insights, Recent Developments

Metabolomics Market by Product (GC, HPLC, UPLC, NMR, Mass Spectrometry, Surface-based mass analysis, Bioinformatics), Application (Biomarker & Drug Discovery, Nutrigenomics, Toxicology), Indication (Oncology, Cardiology, Inborn Errors) — Forecast

The metabolomics market majorly comprises detection techniques such as mass spectrometry (MS) and nuclear magnetic resonance spectroscopy (NMR), and separation techniques such as gas chromatography. These techniques are used in metabolome studies, primarily in toxicology testing and developing personalized medicine.

Download PDF (Metabolomics Market):

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=218189007

This research report segments this Metabolomics Market based on product and service, application, indication, and region.

Major Market Drivers in Metabolomics Market:

• Availability of government and private funding
• Increasing pharmaceutical and biotech R&D expenditure
• Technological advancements
• Growing demand for personalized medicine
• Increasing the use of metabolomics in toxicology testing

Key Questions Addressed in the Research Study:

• Metabolomics helps identify the type and number of compounds analyzed by making use of several complementary analytical methods and what would be the future of metabolomics instruments in the upcoming years?
• How growing demand for personalized medicine and other factors would change the future of the metabolomics market?

Request Research Sample Pages (Metabolomics Market):

https://www.marketsandmarkets.com/requestsampleNew.asp?id=900

Key Market Growth Trend in Metabolomics:

The growing use of hyphenated technologies is likely to provide the largest growth opportunity for metabolomics market players.

Over the past four years, several hyphenated systems have been launched by market players. Hyphenated technology is a combination of two or more analytical tools. Hyphenated technologies reduce cost by requiring the installation of a single instrument. They also provide ease of operation and require lesser space as compared to the installation of two or more standalone devices. In addition, these technologies have broadened the applications of analytical techniques in the analysis of biomaterials, especially natural products.

Major Key Players in Metabolomics Market;

Prominent players in the global metabolomics market are Thermo Fisher Scientific (U.S.), Agilent Technologies (U.S.), Danaher Corporation (U.S.), Waters Corporation (U.S.), and Shimadzu Corporation (Japan). Other leading players in this market include Bio-Rad Laboratories (U.S.), Bruker Corporation (U.S.),

Metabolomics Market Geographic Analysis - Global Forecast

[286 Pages Report] The global Metabolomics Market is expected to reach USD 2,386.4 million by 2021 from USD 1,209.4 million in 2016, at a CAGR of 14.6% during the forecast period.

Metabolomics Market is a powerful and unique analytical approach for the systematic identification and quantification of small-molecule metabolites, metabolite target analysis, metabolic profiling, and metabolic fingerprinting in various biological systems and samples.

Don’t miss out on business opportunities in Metabolomics Market.

Metabolomics Market majorly comprises detection techniques such as mass spectrometry (MS) and nuclear magnetic resonance spectroscopy (NMR), and separation techniques such as gas chromatography. These techniques are used in metabolome studies, primarily in toxicology testing and developing personalized medicine.

Geographic Analysis:

• Further country-wise breakdown of the Rest of Asia-Pacific Metabolomics Market into South Korea, Australia, New Zealand, and others
• Further country-wise breakdown of the Latin American Metabolomics Market into Brazil, Argentina, and Rest of Latin America

Key Questions Answered In This Research Report:

• Metabolomics helps identify the type and number of compounds analyzed by making use of several complementary analytical methods and what would be the future of metabolomics instruments in the upcoming years?
• How growing demand for personalized medicine and other factors would change the future of Metabolomics Market?

Browse and in-depth TOC on “Metabolomics Market”

188 — Tables

42 — Figures

286 — Pages

Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=900

Objectives of the Study;

• To define, describe, and forecast the global Metabolomics Market on the basis of product & service, application, indication, and region
• To provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
• To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall market
• To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of the Metabolomics Market with respect to North America, Europe, Asia- Pacific, Latin America, and the Middle East & Africa

Request for Free Sample Report @

https://www.marketsandmarkets.com/pdfdownload.asp?id=900

Growing Demand for Personalized Medicine Drive the Metabolomics Market;

The growing focus on personalized medicine has driven the use of metabolomics tools by manufacturers engaged in developing rigorous strategies for understanding the root of a disease rather than simply treating a patient’s symptoms. Recent developments in analytical technologies, such as the emergence of high-resolution mass spectrometry, have provided revolutionary analytical capabilities in metabolomics, offering the detection of more than 10,000 metabolites at a given point of time.

Such developments are opening new opportunities for the utilization of metabolomics in the development of personalized and precision medicine. Considering significant developments in the field of metabolomics, coupled with the increasing focus of industry participants to leverage the advantages of metabolomics approaches in the development of personalized medicine, the market is expected to witness significant growth in the coming years.

Metabolomics Market Analysis, Segments, Key Players, Drivers, Trends and Forecast 2021

The Metabolomics Market is expected to grow at a CAGR of 14.6% during the forecast period (2016–2021) to reach USD 2.39 Billion by 2021.

According to the new market research report “Metabolomics Market by Product (GC, HPLC, UPLC, NMR, Mass Spectrometry, Surface-based mass analysis, Bioinformatics), Application (Biomarker & Drug Discovery, Nutrigenomics, Toxicology), Indication (Oncology, Cardiology, Inborn Errors) — Forecast to 2021”, published by MarketsandMarkets™. The global metabolomics market was valued at USD 1.03 Billion in 2016.

Don’t miss out on business opportunities in Metabolomics Market.

Speak to our analyst and gain crucial industry insights that will help your business grow:

https://www.marketsandmarkets.com/speaktoanalyst.asp?id=900

The metabolomics market has witnessed significant growth primarily due to the increasing need advanced technologies. However, need for well-qualified researchers, issues related to data examination and processing, and the high cost of tools and instruments are restraining the growth of this market.

In this report, the market is majorly segmented by product and service, application, indication, and region. Based on product and service, the market is segmented into metabolomics instruments and metabolomics bioinformatics tools & services. The metabolomics instruments segment accounted for largest share of global metabolomics market in 2015. The metabolomics bioinformatics tools & services segment is expected to grow at the highest CAGR during the forecast period. This is attributed to the smooth technological workflow in metabolomics and rapid, precise, reliable, and transparent data processing benefits gained from it.

Browse and in-depth TOC on “Metabolomics Market”

188 — Tables

42 — Figures

286 — Pages

View more detailed TOC @

https://www.marketsandmarkets.com/Market-Reports/metabolomics-technology-market-900.html

On the basis of application, the market is segmented into biomarker discovery, drug discovery, nutrigenomics, toxicology testing, personalized medicine, functional genomics, and others. In 2015, the biomarker discovery segment accounted for the largest share of the global metabolomics market. This is mainly attributed to the improvement in both the efficiency and reliability of metabolic profiling of biomarkers and the accurate and clinically useful diagnostic capabilities of metabolic biomarkers for the management of diseases at the metabolic level. However, the personalized medicine segment is expected to register the highest CAGR during the forecast period due to collaborations between pharmaceutical companies and biotechnology firms for biomarker discovery and validation.

In 2015, North America accounted for the largest share of the metabolomics market, followed by Europe. Easy accessibility to technologically advanced products and the presence of a large number of leading metabolomics manufacturers in the region are driving market growth in North America. Similarly, the rising acceptance of personalized medicines, increasing metabolomics research activities, and growing adoption of technologically advanced products are driving the growth of the North American metabolomics market. The Asia-Pacific region is expected to witness the highest growth in this market majorly due to improving biopharmaceutical research infrastructure, large population, rising healthcare needs, growing per capita income, and growing economies in Japan and India. In addition, manufacturers are increasingly focusing on strengthening their presence in emerging markets of APAC countries.

Request for Free Sample Report @

https://www.marketsandmarkets.com/pdfdownload.asp?id=900

The global metabolomics market is highly competitive in nature, with the top five companies accounting for the major market share in 2015. Some key players in this market are Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), Shimadzu Corporation (Japan), Metabolon Inc. (U.S.), LECO Corporation (U.S.), Biocrates Life Sciences AG (Austria), Human Metabolome Technologies, Inc. (Japan), and Waters Corporation (U.S.). These leading players have primarily focused on product launches, acquisitions, agreements, collaborations, partnerships, and expansions for growth in the market.

Browse Adjacent Markets @ Biotechnology Market Research Reports & Consulting

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact Us:
 Mr. Shelly Singh
 MarketsandMarkets™ INC.
 630 Dundee Road
 Suite 430
 Northbrook, IL 60062
 USA: +1–888–600–6441
 Email: sales@marketsandmarkets.com

Research Insight:https://www.marketsandmarkets.com/ResearchInsight/metabolomics-technology-market.asp

Visit Our Website: https://www.marketsandmarkets.com

Global Metabolomics Market 2018 Research, Industry Trends, Supply, Sales, Demands, Analysis & Insights

The global market was valued at USD 1.03 Billion in 2016. This market is expected to grow at a CAGR of 14.6% during the forecast period (2016–2021) to reach USD 2.39 Billion by 2021.

According to a new market research report “Metabolomics Market by Product (GC, HPLC, UPLC, NMR, Mass Spectrometry, Surface based mass analysis, Bioinformatics), Application (Biomarker & Drug Discovery, Nutrigenomics, Toxicology), Indication (Oncology, Cardiology, Inborn Errors) — Forecast to 2021”.

Browse 188 market data Tables and 42 Figures spread through 286 Pages and in-depth TOC on “Metabolomics Market”

http://www.marketsandmarkets.com/Market-Reports/metabolomics-technology-market-900.html

The metabolomics market has witnessed significant growth primarily due to the increasing need for accurate diagnosis of diseases, rising demand for personalized medicine, and emergence of advanced technologies.

However, need for well-qualified researchers, issues related to data examination and processing, and the high cost of tools and instruments are restraining the growth of this market.

Metabolomics Market

In this report, the market is majorly segmented by product and service, application, indication, and region. Based on product and service, the market is segmented into metabolomics instruments and metabolomics bioinformatics tools & services.

The metabolomics instruments segment accounted for largest share of global metabolomics market in 2015. The metabolomics bioinformatics tools & services segment is expected to grow at the highest CAGR during the forecast period. This is attributed to the smooth technological workflow in metabolomics and rapid, precise, reliable, and transparent data processing benefits gained from it.

Speak To Analyst:http://www.marketsandmarkets.com/speaktoanalyst.asp?id=900

On the basis of application, the market is segmented into biomarker discovery, drug discovery, nutrigenomics, toxicology testing, personalized medicine, functional genomics, and others.

The biomarker discovery segment accounted for the largest share of the global metabolomics market. This is mainly attributed to the improvement in both the efficiency and reliability of metabolic profiling of biomarkers and the accurate and clinically useful diagnostic capabilities of metabolic biomarkers for the management of diseases at the metabolic level.

However, the personalized medicine segment is expected to register the highest CAGR during the forecast period due to collaborations between pharmaceutical companies and biotechnology firms for biomarker discovery and validation.

North America accounted for the largest share of the metabolomics market, followed by Europe. Easy accessibility to technologically advanced products and the presence of a large number of leading metabolomics manufacturers in the region are driving market growth in North America.

Similarly, the rising acceptance of personalized medicines, increasing metabolomics research activities, and growing adoption of technologically advanced products are driving the growth of the North American metabolomics market.

The Asia-Pacific region is expected to witness the highest growth in this market majorly due to improving biopharmaceutical research infrastructure, large population, rising healthcare needs, growing per capita income, and growing economies in Japanand India. In addition, manufacturers are increasingly focusing on strengthening their presence in emerging markets of APAC countries.

Download PDF Brochure@http://www.marketsandmarkets.com/pdfdownload.asp?id=900

The global metabolomics market is highly competitive in nature, with the top five companies accounting for the major market share in 2015. Some key players in this market are Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), Shimadzu Corporation (Japan), Metabolon Inc. (U.S.), LECO Corporation (U.S.), Biocrates Life Sciences AG (Austria), Human Metabolome Technologies, Inc. (Japan), and Waters Corporation (U.S.). These leading players have primarily focused on product launches, acquisitions, agreements, collaborations, partnerships, and expansions for growth in the market.

About MarketsandMarkets™ -

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “RT” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact Us:
 Mr. Shelly Singh
 MarketsandMarkets™ INC.
 630 Dundee Road
 Suite 430
 Northbrook, IL 60062
 USA: +1–888–600–6441
 Email: sales@marketsandmarkets.com

Metabolomics Market Analyzed Globally by Top Key Players, Trends, Share, Growth Rate and Forecast 2021

The Research Report on Metabolomics Market, By Considering useful aspects like; Application, End Users- Global Future Forecast till 2021, published by MarketsandMarkets™, the report studies the global Metabolomics market over the forecast period to 2021.

The study estimates the Metabolomics market size for 2018 and projects its demand till 2021. In the primary research process, various sources from both demand side and supply side were interviewed to obtain qualitative and quantitative information for the report. Primary sources from the demand side include research scientists, Metabolomics specialists, laboratory technicians, and R&D professionals of pharmaceutical and biotechnology companies and academic research institutes.

The Metabolomics market is fragmented with the presence of emerging players;
The global metabolomics market is dominated by large market players such as Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), Waters Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Shimadzu Corporation (Japan), Biocrates Life Sciences AG (Austria), Human Metabolome Technologies Inc. (Japan), LECO Corporation (U.S.), and Metabolon Inc. (U.S)…..Read More

Request a Sample Copy of “Metabolomics Market” Consist 188 tables and 42 figures spread over 259 pages and in-depth TOC: https://www.marketsandmarkets.com/requestsample.asp?id=900

Metabolomics Market, by Product & Service;
· Metabolomic Instruments
· Metabolomic Bioinformatics Tools and Services

Metabolomics Market, by Region;
· North America (US, Canada)
· Europe (UK, Germany, Others)
· Asia
· Rest of the World

For any queries Speak to our Analyst:
https://www.marketsandmarkets.com/speaktoanalyst.asp?id=900

Major Key Points from Table of Content:
· Introduction
· Research Methodology
· Metabolomics Market, By Product & Service
· Metabolomics Market, By Application
· Technology Investment Potential
· Competitive Landscape
· Company Profiles

Major Key Points from List of Tables (Consist of 188 Tables):
· North America: Metabolomics Instruments Market Size for Separation Tools, By Type, 2021 (USD Million)
· U.S.: Metabolomics Market Size, By Product & Service, 2021 (USD Million)
· Canada: Metabolomics Market Size, By Indication, 2021 (USD Million)
· Europe: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2021 (USD Million)……. Click To Read Full Toc

Download Research Sample Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=900